The federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Dompe U.S. Inc., a foreign-owned pharmaceutical manufacturer. The BPA, valued at $2.4 million, is for the procurement of Oxervate Ophthalmic Solution, a medication used to treat neurotrophic keratitis.
Dompe U.S. Inc. has also received multiple firm fixed price delivery orders against its General Services Administration (GSA) Federal Supply Schedule (FSS-61-IB) contract to provide Oxervate to various VA Integrated Service Networks across the country. Additionally, Dompe holds a $5 million FSS schedule contract for broader pharmaceutical supplies, as well as a previous $10 million BPA with the VA. These contract vehicles have enabled Dompe to continue supplying Oxervate and other critical medications to meet the healthcare needs of veterans.
Generated 12/11/24, 9:06 AM